A Study to Evaluate Safety, Tolerability, and Efficacy Profile of Rivoceranib With Paclitaxel in Advanced Gastric or Gastroesophageal Junction Cancer
Clinical trial NCT03707028 · TERMINATED
Trial details
- NCT number
- NCT03707028
- Sponsor
- Elevar Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-01
- Primary completion
- 2021-08-24
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.